MRg-NIRS Imaging System Breast Cancer Trial

Recruiting now · Not applicable

Conditions studied: Breast Cancer

In brief

This trial is a study of 20 women with breast cancer to evaluate the addition of MR-guided (MRg) near-infrared spectroscopy (NIRS) with and without contrast, as part of a program to improve clinical management of women receiving breast magnetic resonance imaging (MRI).

Key facts

Study ID

NCT06400563

Run by

Keith D. Paulsen

People needed

20

Starts

2024-11-25

Expected to finish

2034-07-01

Last updated by the study team

2026-06-23

Who can join

Age: 18 and older, up to 83. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females age ≥ 18 years old
• Participants capable of providing written informed consent
• Women with a recent diagnosis of breast cancer.
• Women who are in pre-surgical planning must have an estimated tumor size of 2.0 cm or less on available imaging.
• Women who are in pre-surgical planning must have had a breast biopsy at least 10 days prior to the MRg-NIRS exam.

You may not qualify if…

• Participants with absolute or relative contraindication to MRI:
• the presence of an electronic implant, such as a pacemaker
• the presence of a metal implant, such as an aneurysm clip
• claustrophobia
• renal failure (FDA's guidance for gadolinium of a creatinine clearance less than 30 mL/1.73 m2 BSA)
• Pregnant women
• Breast implants
• Prisoners
• Participants with visually inadequate healing from breast biopsy.

Where it is running

• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.